Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Nasal & Pulmonary Drug Development
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025

Moderna to expand UK manufacturing capabilities

Last week, mRNA king Moderna revealed plans to build a UK research, development, and manufacturing facility.

Moderna said the facility should be up and running by 2025, with construction set to begin in early 2023. Once operational, the Moderna Innovation and Technology Centre (MITC) will provide the UK with access to domestically manufactured mRNA vaccines as well as pandemic response capabilities, supporting the government’s efforts to reduce the impact of future pandemics with its “100 Days Mission” plan.

The site comes as a result of a ten-year partnership between Moderna and the UK government announced in June of 2022. Recently, the UK’s medicines regulator granted Moderna conditional authorization for the use of its Omicron-containing bivalent COVID-19 booster vaccine, marking the first global approval for an Omicron-targeted shot.

Scott Pharma – 25.03.2025
SMI – 24/03/2025
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
L.B. Bohle – 08.04.2025